Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 102 citing articles:

Phenotypic Plasticity: Driver of Cancer Initiation, Progression, and Therapy Resistance
Piyush B. Gupta, Ievgenia Pastushenko, Adam Skibinski, et al.
Cell stem cell (2018) Vol. 24, Iss. 1, pp. 65-78
Open Access | Times Cited: 497
Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next-Generation Sequencing for Matching Patients to Targeted and Immune Therapies
James J. Harding, Subhiksha Nandakumar, Joshua Armenia, et al.
Clinical Cancer Research (2018) Vol. 25, Iss. 7, pp. 2116-2126
Open Access | Times Cited: 496
HDAC11 Regulates Glycolysis through the LKB1/AMPK Signaling Pathway to Maintain Hepatocellular Carcinoma Stemness
Lei Bi, Yidan Ren, Maoxiao Feng, et al.
Cancer Research (2021) Vol. 81, Iss. 8, pp. 2015-2028
Open Access | Times Cited: 118
Pregnane X receptor mediates sorafenib resistance in advanced hepatocellular carcinoma
Fan Feng, Qiyu Jiang, Shuang Cao, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2018) Vol. 1862, Iss. 4, pp. 1017-1030
Closed Access | Times Cited: 89
STAT3/HOTAIR Signaling Axis Regulates HNSCC Growth in an EZH2-dependent Manner
Shanshan Sun, Yansheng Wu, Wenyu Guo, et al.
Clinical Cancer Research (2018) Vol. 24, Iss. 11, pp. 2665-2677
Open Access | Times Cited: 85
PD-L1 tumor-intrinsic signaling and its therapeutic implication in triple-negative breast cancer
Chunhua Chen, Shiheng Li, Junli Xue, et al.
JCI Insight (2021) Vol. 6, Iss. 8
Open Access | Times Cited: 60
The Impact of Oxidative Stress and AKT Pathway on Cancer Cell Functions and Its Application to Natural Products
Jun‐Ping Shiau, Ya-Ting Chuang, Jen‐Yang Tang, et al.
Antioxidants (2022) Vol. 11, Iss. 9, pp. 1845-1845
Open Access | Times Cited: 41
Exploiting transcription factors to target EMT and cancer stem cells for tumor modulation and therapy
Abdul Quaiyoom Khan, Adria Hasan, Snober S. Mir, et al.
Seminars in Cancer Biology (2024) Vol. 100, pp. 1-16
Closed Access | Times Cited: 14
Bone marrow mesenchymal stem cells suppress growth and promote the apoptosis of glioma U251 cells through downregulation of the PI3K/AKT signaling pathway
Li Lü, Guohu Chen, Jingjing Yang, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 112, pp. 108625-108625
Open Access | Times Cited: 71
Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic Strategies
Monica Mossenta, Davide Busato, Michele Dal Bo, et al.
Cancers (2020) Vol. 12, Iss. 6, pp. 1668-1668
Open Access | Times Cited: 68
Senescence-Associated Pro-inflammatory Cytokines and Tumor Cell Plasticity
Jean‐Paul Vernot
Frontiers in Molecular Biosciences (2020) Vol. 7
Open Access | Times Cited: 63
Inhibition of the PI3K/Akt signaling pathway reverses sorafenib‑derived chemo‑resistance in hepatocellular carcinoma
Hao Zhang, Qingqing Wang, Jun Liu, et al.
Oncology Letters (2018)
Open Access | Times Cited: 62
Ferulic acid reverses P-glycoprotein-mediated multidrug resistance via inhibition of PI3K/Akt/NF-κB signaling pathway
Ganesan Muthusamy, Srithar Gunaseelan, N. Rajendra Prasad
The Journal of Nutritional Biochemistry (2018) Vol. 63, pp. 62-71
Closed Access | Times Cited: 60
Integrated molecular signaling involving mitochondrial dysfunction and alteration of cell metabolism induced by tyrosine kinase inhibitors in cancer
María Hernández, Patricia de la Cruz‐Ojeda, Ma José López-Grueso, et al.
Redox Biology (2020) Vol. 36, pp. 101510-101510
Open Access | Times Cited: 55
Link of sorafenib resistance with the tumor microenvironment in hepatocellular carcinoma: Mechanistic insights
Xinchen Tian, Tinghao Yan, Fen Liu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 36
LncRNA PTENP1/miR-21/PTEN Axis Modulates EMT and Drug Resistance in Cancer: Dynamic Boolean Modeling for Cell Fates in DNA Damage Response
Shantanu Gupta, Daner A. Silveira, P Lorenzoni, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8264-8264
Open Access | Times Cited: 6
Mechanisms of Anticancer Drug Resistance in Hepatoblastoma
José J.G. Marı́n, Candela Cives-Losada, Maitane Asensio, et al.
Cancers (2019) Vol. 11, Iss. 3, pp. 407-407
Open Access | Times Cited: 54
RETRACTED ARTICLE: Hispidulin induces ER stress-mediated apoptosis in human hepatocellular carcinoma cells in vitro and in vivo by activating AMPK signaling pathway
Mei Han, Hui Gao, Jing Xie, et al.
Acta Pharmacologica Sinica (2018) Vol. 40, Iss. 5, pp. 666-676
Open Access | Times Cited: 52
Characterization of Factors Involved in Localized Translation Near Mitochondria by Ribosome-Proximity Labeling
Dikla Vardi-Oknin, Yoav Arava
Frontiers in Cell and Developmental Biology (2019) Vol. 7
Open Access | Times Cited: 52
Contribution of Epithelial Plasticity to Therapy Resistance
Patricia G. Santamarı́a, Gema Moreno‐Bueno, Amparo Cano
Journal of Clinical Medicine (2019) Vol. 8, Iss. 5, pp. 676-676
Open Access | Times Cited: 50
Cancer stem cells, epithelial-mesenchymal transition, ATP and their roles in drug resistance in cancer
Haiyun Zhang, Alexander Steed, Milo Co, et al.
Cancer Drug Resistance (2021)
Open Access | Times Cited: 34
Resistance of Lenvatinib in Hepatocellular Carcinoma
Qiuran Xu, Dong‐Sheng Huang, Jinhui Guo, et al.
Current Cancer Drug Targets (2022) Vol. 22, Iss. 11, pp. 865-878
Closed Access | Times Cited: 26
Ets1 mediates sorafenib resistance by regulating mitochondrial ROS pathway in hepatocellular carcinoma
Kanchan Vishnoi, Rong Ke, Navin Viswakarma, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 7
Open Access | Times Cited: 24
Recent progress in the emerging role of exosome in hepatocellular carcinoma
Mubalake Abudoureyimu, Hao Zhou, Yingru Zhi, et al.
Cell Proliferation (2018) Vol. 52, Iss. 2
Open Access | Times Cited: 40
PI3K/Akt/HIF-1α signaling pathway mediates HPV-16 oncoprotein-induced expression of EMT-related transcription factors in non-small cell lung cancer cells
Jinhua Liu, Bingyu Huang, Zihan Xiu, et al.
Journal of Cancer (2018) Vol. 9, Iss. 19, pp. 3456-3466
Open Access | Times Cited: 39
Page 1 - Next Page

Scroll to top